EXOSENS ANNOUNCES 2024 ESTIMATED RESULTS ABOVE IPO GUIDANCE; 2025 GUIDANCE HIGHLIGHTING LOW TWENTIES ADJUSTED EBITDA GROWTH PRESS RELEASEMÉRIGNAC, FRANCE– 8th JANUARY 2025 2024 estimated figures showing strong revenue growth and sustained profitability, above guidance provided at IPOContinued strong performance expected in 2025, with revenue growth in the high-teens and adjusted EBITDA growth in the low twentiesOverall increased market demand further improves the perspectives which implies a high-teens 2024-2026 adjusted EBITDA CAGR Exosens (Ticker: EXENS; ISIN: FR001400Q9V2), a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, today publishes full-year 2024 unaudited estimated revenue and adjusted EBITDA, its guidance for full-year 2025 as well as its outlook.2024 estimated figures, above guidance provided at IPO Based on unaudited estimated figures, the Group expects for full-year 2024: Total revenue of between €390–395 million, representing a growth of more than 34% compared to full-year 2023;Adjusted EBITDA of between €116–118 million, representing an adjusted EBITDA margin of around 30%.
These forward-looking statements are based on current beliefs, expectations and assumptions, including, without limitation, assumptions regarding present and future business strategies and the environment in which Exosens operates, and involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to be materially different from the forward-looking statements included in this press release.
Outlook for 2025 and the 2024-2026 period The Group expects continued strong performance in 2025, with revenue growth in the high-teens and adjusted EBITDA growth in the low twenties compared to full year 2024.
The story "Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth" has 759 words across 23 sentences, which will take approximately 4 - 7 minutes for the average person to read.
Which news outlet covered this story?
The story "Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth" was covered 2 weeks ago by GlobeNewswire, a news publisher based in China.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.
The outlet is headquartered in China and publishes an average of 78 news stories per day.
It's most recent story was published 9 hours ago.
What do people currently think of this news story?
The sentiment for this story is currently Negative, indicating that people regard this as "bad news".
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
